Breaking News - The Fly

Open Search

INDP

Indaptus Therapeutics

$

()

Indaptus presents mechanism of action data at AACR for Decoy platform

INDP

4/11/2024 - 07:32am

Indaptus Therapeutics previews presentation of mechanism of action data

INDP

3/25/2024 - 08:52am

Indaptus Therapeutics expects cash to support activities through 3Q24

INDP

3/13/2024 - 07:32am

Indaptus Therapeutics reports 2023 EPS ($1.83) vs. ($1.73) last year

INDP

3/13/2024 - 07:32am

Indaptus announces results from second cohort in Phase 1 INDP-D101 trial

INDP

3/4/2024 - 07:33am

Indaptus Therapeutics launches new social media initiative to provide education

INDP

2/8/2024 - 08:09am

Indaptus Therapeutics to receive European patent for platform technology

INDP

1/4/2024 - 08:32am

Indaptus Therapeutics announces interim data from Phase 1 INDP-D101 trial

INDP

11/6/2023 - 08:13am

Indaptus to present interim data of first cohort in trial of INDP-D101

INDP

10/31/2023 - 09:12am

Indaptus Therapeutics doses first patient in second cohort of study of Decoy20

INDP

9/19/2023 - 08:03am

Indaptus Therapeutics reports Q2 EPS (39c) vs (46c) last year

INDP

8/14/2023 - 08:02am

Indaptus Therapeutics announces opening of next cohort in trial of Decoy20

INDP

8/10/2023 - 08:46am

Indaptus Therapeutics appoints Waltzman as Chief Medical Officer

INDP , MTEM

8/7/2023 - 08:09am

Indaptus Therapeutics expects cash to fund operations into 2Q24

INDP

5/11/2023 - 07:06am

Indaptus Therapeutics reports Q1 EPS (51c) vs. (41c) last year

INDP

5/11/2023 - 07:05am